Bavarian Nordic appoints Nicolai Buhl Andersen as Executive Vice President, Commercial Affairs

Bavarian Nordic has appointed Nicolai Buhl Andersen to head the newly
established commercial function. He will join the company on 16
November 2007 as Executive Vice President, Commercial Affairs, and as
part of Corporate Management he will be reporting to President & CEO,
Anders Hedegaard.

Nicolai Buhl Andersen (born 1969) comes from Coloplast where he
currently holds the position as Senior Vice President, Commercial
Excellence. He has more than eight years of international experience
in leading positions in the field of sales and marketing from Novo
Nordisk. He holds a M.Sc. in Economics and Business Administration
from Copenhagen Business School.

Anders Hedegaard, President & CEO of Bavarian Nordic, said: "With
great international experience in sales and marketing, Nicolai Buhl
Andersen has the ideal profile to head Bavarian Nordic's global
commercial activities. The establishment of the commercial function
as separate business area marks an important milestone for the
company as it does not only strengthen our ongoing sales efforts for
our third generation smallpox vaccine, IMVAMUNE® , but also ensures
the integration of important market knowledge in the R&D activities
so that these will focus even more on the commercial opportunities."




Asger Aamund
Chairman



Contacts:

Anders Hedegaard, President & CEO
Telephone: +45 33 26 83 83

Media: United Kingdom
Mary Clark, Capital MS&L
Telephone: +44 207 307 5330

Media: United States of America
Elizabeth Dempsey Becker, Bavarian Nordic Inc.
Telephone: +1 202 536-1576